Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing specimens for Chlamydia trachomatis.

S Skidmore1, P Horner, H Mallinson

  • 1Department of Microbiology, Princess Royal Hospital, Telford TF1 6TF, UK. sue.skidmore@rsh.nhs.uk

Sexually Transmitted Infections
|August 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Human Embryonic Stem Cell-Derived Dopaminergic Neuron Progenitor Transplants Using Non-invasive Imaging Techniques.

Molecular imaging and biology·2020
Same author

Response to White and Lewis: Letter to editor in response to Has <i>Chlamydia trachomatis</i> prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys. <i>Epidemiology and Infection. 2019</i>.

Epidemiology and infection·2019
Same author

Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys.

Epidemiology and infection·2019
Same author

Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Clinical microbiology reviews·2015
Same author

2015 UK National Guideline on the management of non-gonococcal urethritis.

International journal of STD & AIDS·2015
Same journal

Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia.

Sexually transmitted infections·2026
Same journal

Insights into sexual partners and partnerships among gay, bisexual and other men who have sex with men in the United Kingdom: results from the Reducing Inequalities in Sexual Health (RiiSH) behavioural survey.

Sexually transmitted infections·2026
Same journal

Deep genomic characterisation of an extensively drug-resistant <i>Shigella sonnei</i> carrying bla <i><sub>CTX-M-15</sub></i> in a sexually transmitted infection in an MSM patient in Spain.

Sexually transmitted infections·2026
Same journal

National prevalence estimates of chlamydia and gonorrhoea in the Netherlands (PECAN): comparison of two national cross-sectional surveys.

Sexually transmitted infections·2026
Same journal

STI-driven antibiotic exposure may shape macrolide and tetracycline resistance in nasal <i>Staphylococcus aureus</i> among MSM receiving HIV pre-exposure prophylaxis.

Sexually transmitted infections·2026
Same journal

Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in Australia.

Sexually transmitted infections·2026
See all related articles

Nucleic acid amplification tests (NAATs) are the standard for diagnosing chlamydia, but implementing these advanced tests presents challenges. This review addresses common questions for those starting chlamydia screening programs.

Area of Science:

  • Clinical diagnostics
  • Microbiology
  • Public health

Background:

  • Nucleic acid amplification tests (NAATs) have become the gold standard for diagnosing chlamydial infections.
  • The widespread adoption of NAATs has significantly improved diagnostic accuracy and efficiency.
  • Despite their success, NAATs introduce new considerations and challenges in clinical practice.

Purpose of the Study:

  • To address practical questions arising from the implementation of NAATs for chlamydial diagnostics.
  • To provide an updated overview of the current landscape of chlamydial screening using NAATs.
  • To guide laboratories and public health groups initiating chlamydia screening programs.

Main Methods:

  • This study is a review of current literature and clinical guidelines.

Related Experiment Videos

  • It synthesizes information regarding the application and challenges of NAATs in chlamydia diagnostics.
  • The review focuses on practical aspects relevant to screening program implementation.

    • Main Results:

    • NAATs offer high sensitivity and specificity for detecting Chlamydia trachomatis.
    • Key challenges include cost, workflow integration, and interpretation of results.
    • The review highlights the importance of understanding test performance characteristics and quality control.

    Conclusions:

    • NAATs represent a significant advancement in chlamydial diagnostics, establishing a new standard of care.
    • Careful planning and consideration of logistical and clinical factors are crucial for successful screening program implementation.
    • This review serves as a valuable resource for healthcare professionals navigating the complexities of NAAT-based chlamydia screening.